share_log

Conduit Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Hudson Bay Capital Management LP(0.10%),Sander Gerber(0.10%)

SEC ·  Feb 3 05:33
Summary by Futu AI
On December 31, 2023, Hudson Bay Capital Management LP, an investment management firm based in Delaware, and Sander Gerber, its managing member, filed an amended Schedule 13G/A with the SEC, indicating a change in their holdings of Conduit Pharmaceuticals Inc. The filing revealed that Hudson Bay Capital Management LP and Sander Gerber collectively own 73,078 shares of Conduit Pharmaceuticals' common stock, which are issuable upon the exercise of warrants. This represents 0.10% of the company's class of securities, based on 73,829,536 shares outstanding as of December 15, 2023. The shares are held by HB Strategies LLC, with the Investment Manager serving as the investment manager to HB Strategies LLC. Sander Gerber, as the managing member of Hudson Bay Capital GP LLC, which is the general partner of the Investment Manager, disclaims beneficial ownership of these securities. The filing also certifies that the securities were acquired in the ordinary course of business and not for the purpose of changing or influencing the control of Conduit Pharmaceuticals.
On December 31, 2023, Hudson Bay Capital Management LP, an investment management firm based in Delaware, and Sander Gerber, its managing member, filed an amended Schedule 13G/A with the SEC, indicating a change in their holdings of Conduit Pharmaceuticals Inc. The filing revealed that Hudson Bay Capital Management LP and Sander Gerber collectively own 73,078 shares of Conduit Pharmaceuticals' common stock, which are issuable upon the exercise of warrants. This represents 0.10% of the company's class of securities, based on 73,829,536 shares outstanding as of December 15, 2023. The shares are held by HB Strategies LLC, with the Investment Manager serving as the investment manager to HB Strategies LLC. Sander Gerber, as the managing member of Hudson Bay Capital GP LLC, which is the general partner of the Investment Manager, disclaims beneficial ownership of these securities. The filing also certifies that the securities were acquired in the ordinary course of business and not for the purpose of changing or influencing the control of Conduit Pharmaceuticals.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.